André Guedel

André Guedel

Head of International Headquarters

Expanding right into Europe

Innovation is the life source of Life Sciences. But strategic and meticulous planning is key to commercial success, especially when entering a new regional market.

Switzerland’s attractiveness for multinational corporations at risk

Multinational corporations are in permanent business transformation mode. Many of them have located key value drivers in Switzerland because of the country’s flexibility and stable business environment. But will Switzerland remain attractive as companies seek to transform their business towards fast and sustainable growth?
12

Smart Site Selection for Life Sciences Companies

Life science companies have to future-proof their value chain by placing functions, assets and risks in locations where they are planning to have their profits taxed. Structures where profit allocations are made in tax-beneficent locations with little or no substance are no longer viable.
8

How attractive are European Life Sciences Sites?

KPMG’s newest report on leading Life Sciences Clusters in Europe, released on 3 November 2015 at the Bio Europe Congress, reveals important differences between different countries in Europe and their attractiveness for Foreign Direct Investments for the Life Sciences Industry.
16

How to read International Site Selection Rankings

Rankings and indices play an important role in site selection. However, the devil is in the detail, and every ranking or index has to be critically questioned before being used to select a location.
10

Switzerland – your gateway to Europe

Multinational companies (MNCs) are under an ever increasing pressure from their stakeholders and from the markets to provide for growth prospects which are at the same time competitive and sustainable. One of the key success factors in this regards is choosing the right location for the right activities.
8